Reda Stankunaite

Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

M. Fischer, N. Blüthgen, M. Hubank, 2022, Molecular cancer.

Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours.

A. Sottoriva, H. Mandeville, M. Hubank, 2021, European journal of cancer.

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study

D. Surdez, O. Delattre, B. Schäfer, 2022, JCO precision oncology.

Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerations

M. Hubank, L. Chesler, L. Marshall, 2022, Frontiers in Pediatrics.

Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma

S. Al-Sarraj, Sara Temelso, J. Grill, 2021, Cancer discovery.